Featured Publications
Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury–Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant
Dandoy CE, Kim S, Chen M, Ahn KW, Ardura MI, Brown V, Chhabra S, Diaz MA, Dvorak C, Farhadfar N, Flagg A, Ganguly S, Hale GA, Hashmi SK, Hematti P, Martino R, Nishihori T, Nusrat R, Olsson RF, Rotz SJ, Sung AD, Perales MA, Lindemans CA, Komanduri KV, Riches ML. Incidence, Risk Factors, and Outcomes of Patients Who Develop Mucosal Barrier Injury–Laboratory Confirmed Bloodstream Infections in the First 100 Days After Allogeneic Hematopoietic Stem Cell Transplant. JAMA Network Open 2020, 3: e1918668. PMID: 31913492, PMCID: PMC6991246, DOI: 10.1001/jamanetworkopen.2019.18668.Peer-Reviewed Original ResearchMeSH KeywordsAdultBacteremiaCatheter-Related InfectionsCross InfectionFemaleHematopoietic Stem Cell TransplantationHumansIncidenceMaleMiddle AgedMucous MembraneRetrospective StudiesRisk FactorsConceptsHematopoietic stem cell transplantAllogeneic hematopoietic stem cell transplantMucosal barrier injury laboratoryMBI-LCBIOutcomes of patientsStem cell transplantBloodstream infectionsCumulative incidenceCell transplantRisk factorsDay 100First allogeneic hematopoietic stem cell transplantMarrow Transplant Research databaseHost disease (GVHD) prophylaxisLansky performance statusTransplant-related mortalityOne-year mortalityTranslocation of bacteriaCord blood graftsCause of deathChronic graftConsecutive pediatricHost diseaseMyeloablative conditioningAdult patients
2017
Mycobacterium genavense‐induced spindle cell pseudotumor in a pediatric hematopoietic stem cell transplant recipient: Case report and review of the literature
Coelho R, Hanna R, Flagg A, Stempak LM, Ondrejka S, Procop GW, Harrington S, Zembillas A, Kusick K, Gonzalez BE. Mycobacterium genavense‐induced spindle cell pseudotumor in a pediatric hematopoietic stem cell transplant recipient: Case report and review of the literature. Transplant Infectious Disease 2017, 19 PMID: 28039955, DOI: 10.1111/tid.12656.Peer-Reviewed Case Reports and Technical NotesMeSH KeywordsAbdomenAdolescentAlemtuzumabAntibiotic ProphylaxisAntibiotics, AntitubercularAntibodies, Monoclonal, HumanizedBone Marrow TransplantationBronchoalveolar Lavage FluidCyclosporineDiabetes Mellitus, Type 1DiarrheaGenetic Diseases, X-LinkedGraft RejectionGraft vs Host DiseaseHematopoietic Stem Cell TransplantationHistiocytesHumansImmune System DiseasesImmunosuppressive AgentsLymph NodesMaleMelphalanMycobacterium Infections, NontuberculousMycophenolic AcidNontuberculous MycobacteriaPhotopheresisPolymerase Chain ReactionTransplantation ConditioningVidarabine